| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 607657 | 88766 | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCION PARA PULVERIZACION CUTANEA | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCION PARA PULVERIZACION CUTANEA, 50 frascos de 100 ml | 20 mg/ml + 0,49 ml/ml | 6 | 5000 | 26 | 50 frascos de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88766/88766_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88766/88766_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | 39653 | 2023-04-10 | 1 | 1 | 1 | 2023-04-11 | 2023-04-10 | 1 | 2023-06-23 | View Edit Delete | ||||||||||||
| 607658 | 88766 | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCION PARA PULVERIZACION CUTANEA | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCION PARA PULVERIZACION CUTANEA, 50 frascos de 250 ml | 20 mg/ml + 0,49 ml/ml | 6 | 12500 | 26 | 50 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88766/88766_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88766/88766_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | 39653 | 2023-04-10 | 1 | 1 | 1 | 2023-04-11 | 2023-04-10 | 1 | 2023-06-23 | View Edit Delete | ||||||||||||
| 607659 | 88767 | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCIÓN CUTÁNEA | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCIÓN CUTÁNEA, 100 frascos de 10 ml | 20 mg/ml + 0,49 ml/ml | 6 | 1000 | 26 | 100 frascos de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88767/88767_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88767/88767_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | 39653 | 2023-04-10 | 1 | 1 | 1 | 2023-04-11 | 2023-04-10 | 1 | 2023-07-07 | View Edit Delete | ||||||||||||
| 607660 | 88767 | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCIÓN CUTÁNEA | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCIÓN CUTÁNEA, 50 frascos de 100 ml | 20 mg/ml + 0,49 ml/ml | 6 | 5000 | 26 | 50 frascos de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88767/88767_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88767/88767_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | 39653 | 2023-04-10 | 1 | 1 | 1 | 2023-04-11 | 2023-04-10 | 1 | 2023-07-07 | View Edit Delete | ||||||||||||
| 607661 | 88767 | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCIÓN CUTÁNEA | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCIÓN CUTÁNEA, 100 frascos de 20 ml | 20 mg/ml + 0,49 ml/ml | 6 | 2000 | 26 | 100 frascos de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88767/88767_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88767/88767_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | 39653 | 2023-04-10 | 1 | 1 | 1 | 2023-04-11 | 2023-04-10 | 1 | 2023-09-14 | View Edit Delete | ||||||||||||
| 607662 | 88767 | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCIÓN CUTÁNEA | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCIÓN CUTÁNEA, 50 frascos de 250 ml | 20 mg/ml + 0,49 ml/ml | 6 | 12500 | 26 | 50 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88767/88767_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88767/88767_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | 39653 | 2023-04-10 | 1 | 1 | 1 | 2023-04-11 | 2023-04-10 | 1 | 2023-06-23 | View Edit Delete | ||||||||||||
| 607664 | 88767 | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCIÓN CUTÁNEA | CLORXIL CON ALCOHOL ORANGE 20 MG/ML + 0,49 ML/ML SOLUCIÓN CUTÁNEA, 20 frascos de 500 ml | 20 mg/ml + 0,49 ml/ml | 6 | 10000 | 26 | 20 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88767/88767_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88767/88767_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | 39653 | 2023-04-10 | 1 | 1 | 1 | 2023-04-11 | 2023-04-10 | 1 | 2023-07-06 | View Edit Delete | ||||||||||||
| 650144 | 66329 | LIDERFEME 400 mg SUSPENSION ORAL | LIDERFEME 400 mg SUSPENSION ORAL , 12 sobres | 400 mg | 35 | 12 | 64 | 12 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66329/66329_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66329/66329_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8730 | 8730 | 2004-09-14 | 1 | 1 | 1 | 2004-09-14 | 2004-09-14 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 651177 | 65503 | PIREXIN 40 mg/ml SUSPENSION ORAL | PIREXIN 40 mg/ml SUSPENSION ORAL 1 frasco de 150 ml y jeringa oral graduada | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml y jeringa oral graduada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65503/65503_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65503/65503_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 2003-07-18 | 1 | 1 | 1 | 2003-07-18 | 2005-04-21 | 1 | 2024-10-16 | View Edit Delete | ||||||||||||
| 654687 | 67931 | IBUFARMALID 600 mg SUSPENSION ORAL | IBUFARMALID 600 mg SUSPENSION ORAL, 20 sobres | 600 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67931/67931_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67931/67931_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1016 | 1018 | 2006-07-05 | 1 | 1 | 1 | 2006-07-05 | 2006-07-05 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 655870 | 67963 | IBUFARMALID 200 mg SUSPENSION ORAL | IBUFARMALID 200 mg SUSPENSION ORAL, 20 sobres | 200 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67963/67963_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67963/67963_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8730 | 8730 | 2006-07-28 | 1 | 1 | 1 | 2006-07-28 | 2006-07-28 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 656427 | 68200 | IBUFARMALID 400 mg SUSPENSION ORAL | IBUFARMALID 400 mg SUSPENSION ORAL, 30 sobres | 400 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68200/68200_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68200/68200_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6345 | 6345 | 2006-11-27 | 1 | 1 | 1 | 2006-11-27 | 2006-11-27 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 656565 | 68004 | APIROFENO 40 mg/ml SUSPENSION ORAL | APIROFENO 40 mg/ml SUSPENSION ORAL , 1 frasco de 150 ml | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68004/68004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68004/68004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 2006-08-29 | 1 | 1 | 1 | 2006-08-29 | 2007-07-02 | 1 | 2011-09-09 | 655964 | View Edit Delete | |||||||||||
| 656685 | 32357 | TOSEINA 2 mg/ml SOLUCION ORAL | TOSEINA 2 mg/ml SOLUCION ORAL , 1 frasco de 250 ml | 10 mg/5 ml | 6 | 250 | 26 | 1 frasco de 250 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/32357/32357_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/32357/32357_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1473 | 1473 | 1959-07-01 | 1 | 1 | 1 | 1959-07-01 | 2007-09-24 | 1 | 2011-07-11 | 736280 | Lista III | View Edit Delete | ||||||||||
| 658406 | 68436 | TAMSULOSINA SUN 0,4 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | TAMSULOSINA SUN 0,4 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG , 30 cápsulas | 0,4 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68436/68436_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68436/68436_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8873 | 34173 | 2007-01-30 | 1 | 1 | 1 | 2007-01-30 | 2007-01-30 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 659515 | 69085 | FLUCONAZOL TEVA 200 mg CAPSULAS DURAS EFG | FLUCONAZOL TEVA 200 mg CAPSULAS DURAS EFG, 7 cápsulas | 200 mg | 5 | 7 | 43 | 7 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69085/69085_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69085/69085_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2007-07-06 | 1 | 1 | 1 | 2007-07-06 | 2007-07-06 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660782 | 69726 | DALSY 40 mg/ml SUSPENSION ORAL | DALSY 40 mg/ml SUSPENSION ORAL , 1 frasco de 150 ml | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69726/69726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69726/69726_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | 44524 | 2008-04-07 | 1 | 1 | 1 | 2008-04-07 | 2008-04-07 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 661265 | 69955 | APIREDOL 100 mg/ml SOLUCION ORAL | APIREDOL 100 mg/ml SOLUCION ORAL, 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69955/69955_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69955/69955_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7335 | 7335 | 2008-07-11 | 1 | 1 | 1 | 2008-07-11 | 2008-07-11 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 661266 | 69955 | APIREDOL 100 mg/ml SOLUCION ORAL | APIREDOL 100 mg/ml SOLUCION ORAL, 1 frasco de 60 ml | 100 mg/ml | 6 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69955/69955_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69955/69955_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7335 | 7335 | 2008-07-11 | 1 | 1 | 1 | 2008-07-11 | 2008-07-11 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 661267 | 49302 | APIRETAL 100 mg/ml SOLUCION ORAL | APIRETAL 100 mg/ml SOLUCION ORAL, 1 frasco de 90 ml | 100 mg/ml | 6 | 90 | 26 | 1 frasco de 90 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49302/49302_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49302/49302_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 1971-05-01 | 1 | 1 | 1 | 1971-05-01 | 2008-07-14 | 1 | 2011-09-09 | View Edit Delete | ||||||||||||
| 664267 | 68004 | APIROFENO 40 mg/ml SUSPENSION ORAL | APIROFENO 40 mg/ml SUSPENSION ORAL , 1 frasco de 50 ml | 40 mg/ml | 6 | 50 | 26 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68004/68004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68004/68004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 2006-08-29 | 1 | 1 | 1 | 2006-08-29 | 2009-11-19 | 1 | 2011-09-09 | View Edit Delete | ||||||||||||
| 679639 | 61072 | PARACETAMOL/ CODEINA LEVEL 24mg/ml +2,40mg/ml SOLUCION ORAL | PARACETAMOL/ CODEINA LEVEL 24mg/ml +2,40mg/ml SOLUCION ORAL , 1 frasco de 240 ml | 120 mg/5 ml + 12 mg/5 ml | 82 | 240 | 26 | 1 frasco de 240 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61072/61072_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61072/61072_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 1996-11-01 | 1 | 1 | 1 | 1996-11-01 | 1996-11-01 | 1 | 2011-09-09 | Lista III | View Edit Delete | |||||||||||
| 703494 | 79019 | GAVISCON FORTE COMPRIMIDOS MASTICABLES | GAVISCON FORTE COMPRIMIDOS MASTICABLES , 48 comprimidos | 187,5 mg/250 mg/106,5 mg | 5 | 48 | 10 | 48 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79019/79019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79019/79019_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71183 | 71183 | 2014-09-05 | 1 | 1 | 1 | 2014-09-05 | 2014-09-05 | 1 | 2016-02-03 | View Edit Delete | ||||||||||||
| 705802 | 79648 | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 150 MG/37,5 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA CINFA 150 MG/37,5 MG/200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 100 comprimidos | 150 mg/37,5 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79648/79648_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79648/79648_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2015-05-25 | View Edit Delete | ||||||||||||
| 705807 | 79652 | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 150 mg /37,5 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | LEVODOPA/CARBIDOPA/ENTACAPONA KERN PHARMA 150 mg /37,5 mg /200 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 100 comprimidos | 150 mg/37,5 mg/200 mg | 6 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79652/79652_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79652/79652_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | 1534 | 2015-03-20 | 1 | 1 | 1 | 2015-03-20 | 2015-03-20 | 1 | 2017-12-14 | View Edit Delete | ||||||||||||
| 710175 | 68004 | APIROFENO 40 mg/ml SUSPENSION ORAL | APIROFENO 40 mg/ml SUSPENSION ORAL , 1 frasco de 200 ml | 40 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68004/68004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68004/68004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 2006-08-29 | 1 | 1 | 1 | 2006-08-29 | 2016-02-24 | 1 | 2016-06-16 | View Edit Delete | ||||||||||||
| 713430 | 81364 | VENLAFAXINA RETARD TEVA-RATIOPHARM 225 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD TEVA-RATIOPHARM 225 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas (Blister PVC/PVDC-Al) | 225 mg | 5 | 30 | 43 | 30 cápsulas (Blister PVC/PVDC-Al) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81364/81364_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81364/81364_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | 34492 | 2016-10-31 | 1 | 1 | 1 | 2016-11-02 | 2016-10-31 | 1 | 2017-06-13 | View Edit Delete | ||||||||||||
| 714307 | 81636 | VENLAFAXINA BLUEFISH 225 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA BLUEFISH 225 MG CAPSULAS DE LIBERACION PROLONGADA EFG, 30 cápsulas (Blister Al-PVC/PVDC) | 225 mg | 5 | 30 | 43 | 30 cápsulas (Blister Al-PVC/PVDC) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/81636/81636_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/81636/81636_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20763 | 42274 | 2017-01-20 | 1 | 1 | 1 | 2017-01-21 | 2017-01-20 | 1 | 2017-05-22 | View Edit Delete | ||||||||||||
| 719140 | 82453 | VENLAFAXINA RETARD STADAGEN 225 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD STADAGEN 225 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas (Blister Al-PVC/PVDC) | 225 mg | 5 | 30 | 43 | 30 cápsulas (Blister Al-PVC/PVDC) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82453/82453_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82453/82453_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | 6220 | 2017-09-25 | 1 | 1 | 1 | 2017-09-27 | 2017-09-25 | 1 | 2018-06-08 | View Edit Delete | ||||||||||||
| 721434 | 79019 | GAVISCON FORTE COMPRIMIDOS MASTICABLES | GAVISCON FORTE COMPRIMIDOS MASTICABLES,24 comprimidos | 106,50 mg/250 mg/187,5 mg | 5 | 24 | 10 | 24 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79019/79019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79019/79019_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71183 | 71183 | 2014-09-05 | 1 | 1 | 1 | 2014-09-05 | 2018-04-19 | 1 | 2018-10-22 | View Edit Delete | ||||||||||||
| 722077 | 83208 | ANTIDOL INFANTIL 100 MG/ML SOLUCION ORAL | ANTIDOL INFANTIL 100 MG/ML SOLUCION ORAL, 1 frasco de 90 ml | 100 mg/ml | 6 | 90 | 26 | 1 frasco de 90 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83208/83208_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83208/83208_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2018-06-14 | 1 | 1 | 1 | 2018-06-15 | 2018-06-14 | 1 | 2024-05-10 | View Edit Delete | ||||||||||||
| 725851 | 84157 | VENLAFAXINA RETARD NORMON 225 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD NORMON 225 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas (Blister Al/PVC/PVDC) | 225 mg | 5 | 30 | 43 | 30 cápsulas (Blister Al/PVC/PVDC) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84157/84157_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84157/84157_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2019-05-23 | 1 | 1 | 1 | 2019-05-24 | 2019-05-23 | 1 | 2020-01-08 | View Edit Delete | ||||||||||||
| 726476 | 84393 | VENLAFAXINA RETARD SANDOZ 225 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD SANDOZ 225 MG CAPSULAS DURAS DE LIBERACION PROLONGADA EFG, 30 cápsulas | 225 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84393/84393_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84393/84393_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | 23615 | 2019-07-29 | 1 | 1 | 1 | 2019-07-30 | 2019-07-29 | 1 | 2020-11-13 | View Edit Delete | ||||||||||||
| 731101 | 64021 | FEBROVIR 100 MG/ML SOLUCION ORAL | FEBROVIR 100 MG/ML SOLUCION ORAL, 1 frasco de 60 ml + jeringa dosificadora | 100 mg/ml | 6 | 60 | 26 | 1 frasco de 60 ml + jeringa dosificadora | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64021/64021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64021/64021_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | 3050 | 2001-06-26 | 1 | 1 | 1 | 2001-06-26 | 2021-05-31 | 1 | 2021-10-27 | View Edit Delete | ||||||||||||
| 731840 | 86268 | ALPRAZOLAM TECNIGEN 1 MG COMPRIMIDOS EFG | ALPRAZOLAM TECNIGEN 1 MG COMPRIMIDOS EFG, 30 comprimidos | 1 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86268/86268_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86268/86268_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | 12947 | 2021-10-05 | 1 | 1 | 1 | 2021-10-06 | 2021-10-05 | 1 | 2021-11-16 | Lista IV | View Edit Delete | |||||||||||
| 732699 | 86526 | ANTIDOL 1 G SOLUCION ORAL | ANTIDOL 1 G SOLUCION ORAL, 10 sobres de 10 ml | 1.000 mg | 35 | 10 | 64 | 10 sobres de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86526/86526_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86526/86526_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2022-01-21 | 1 | 1 | 1 | 2022-01-22 | 2022-01-21 | 1 | 2023-05-09 | View Edit Delete | ||||||||||||
| 732702 | 86527 | ANTIDOL 500 MG SOLUCION ORAL | ANTIDOL 500 MG SOLUCION ORAL, 20 sobres | 500 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86527/86527_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86527/86527_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | 684 | 2022-01-21 | 1 | 1 | 1 | 2022-01-22 | 2022-01-21 | 1 | 2024-08-13 | View Edit Delete | ||||||||||||
| 732745 | 86539 | ALPRAZOLAM COMBIX 1 MG COMPRIMIDOS EFG | ALPRAZOLAM COMBIX 1 MG COMPRIMIDOS EFG, 30 comprimidos | 1 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86539/86539_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86539/86539_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2022-02-02 | 1 | 1 | 1 | 2022-02-03 | 2022-02-02 | 1 | 2022-09-14 | Lista IV | View Edit Delete | |||||||||||
| 750521 | 49302 | APIRETAL 100 mg/ml SOLUCION ORAL | APIRETAL 100 mg/ml SOLUCION ORAL, 1 frasco de 60 ml | 100 mg/ml | 6 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49302/49302_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49302/49302_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 1971-05-01 | 1 | 1 | 1 | 1971-05-01 | 2004-07-14 | 1 | 2011-09-09 | 886184 | View Edit Delete | |||||||||||
| 750711 | 49302 | APIRETAL 100 mg/ml SOLUCION ORAL | APIRETAL 100 mg/ml SOLUCION ORAL, 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49302/49302_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49302/49302_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 1971-05-01 | 1 | 1 | 1 | 1971-05-01 | 2004-07-14 | 1 | 2011-09-09 | 850362 | View Edit Delete | |||||||||||
| 761525 | 88510 | PARACETAMOL COMBIX 500 MG CAPSULAS DURAS EFG | PARACETAMOL COMBIX 500 MG CAPSULAS DURAS EFG, 24 cápsulas | 500 mg | 5 | 24 | 43 | 24 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88510/88510_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88510/88510_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | 12564 | 2023-01-18 | 1 | 1 | 1 | 2023-01-19 | 2023-01-18 | 1 | 2023-07-11 | View Edit Delete | ||||||||||||
| 763526 | 89078 | RIXACAM 20 MG CÁPSULAS DURAS EFG | RIXACAM 20 MG CÁPSULAS DURAS EFG, 28 cápsulas (PVC/PVDC/Al) | 20 mg | 5 | 28 | 43 | 28 cápsulas (PVC/PVDC/Al) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89078/89078_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89078/89078_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | 16612 | 2024-02-05 | 1 | 1 | 1 | 2024-02-05 | 2024-02-05 | 1 | 2026-02-12 | View Edit Delete | ||||||||||||
| 763644 | 89108 | CAMLAD 16 MG/10 MG/12,5 MG CÁPSULAS DURAS | CAMLAD 16 MG/10 MG/12,5 MG CÁPSULAS DURAS, 30 cápsulas | 16 mg/10 mg/12,5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89108/89108_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89108/89108_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | 45197 | 2023-10-27 | 1 | 1 | 1 | 2023-10-30 | 2023-10-27 | 1 | 2024-04-12 | View Edit Delete | ||||||||||||
| 763739 | 89145 | PARACETAMOL NORMON 100 MG/ML SOLUCIÓN ORAL EFG | PARACETAMOL NORMON 100 MG/ML SOLUCIÓN ORAL EFG, 60 ml | 100 mg/ml | 6 | 60 | 26 | 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89145/89145_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89145/89145_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2023-11-13 | 1 | 1 | 1 | 2023-11-14 | 2023-11-13 | 1 | 2024-04-18 | View Edit Delete | ||||||||||||
| 763742 | 89146 | DIFENATIL INFANTIL 100 MG/ML SOLUCIÓN ORAL | DIFENATIL INFANTIL 100 MG/ML SOLUCIÓN ORAL, 60 ml | 100 mg/ml | 6 | 60 | 26 | 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89146/89146_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89146/89146_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2023-11-13 | 1 | 1 | 1 | 2023-11-14 | 2023-11-13 | 1 | 2024-01-12 | View Edit Delete | ||||||||||||
| 763743 | 89146 | DIFENATIL INFANTIL 100 MG/ML SOLUCIÓN ORAL | DIFENATIL INFANTIL 100 MG/ML SOLUCIÓN ORAL, 90 ml | 100 mg/ml | 6 | 90 | 26 | 90 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89146/89146_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89146/89146_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | 6638 | 2023-11-13 | 1 | 1 | 1 | 2023-11-14 | 2023-11-13 | 1 | 2024-01-12 | View Edit Delete | ||||||||||||
| 766535 | 90036 | POMALIDOMIDA GRINDEKS 3 MG CAPSULAS DURAS EFG | POMALIDOMIDA GRINDEKS 3 MG CAPSULAS DURAS EFG, 21 cápsulas | 3 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90036/90036_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90036/90036_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11528 | 68038 | 2024-12-27 | 1 | 1 | 1 | 2024-12-28 | 2024-12-27 | 1 | 2025-06-27 | View Edit Delete | ||||||||||||
| 766536 | 90037 | POMALIDOMIDA GRINDEKS 4 MG CAPSULAS DURAS EFG | POMALIDOMIDA GRINDEKS 4 MG CAPSULAS DURAS EFG, 21 cápsulas | 4 mg | 5 | 21 | 43 | 21 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90037/90037_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90037/90037_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11528 | 68038 | 2024-12-27 | 1 | 1 | 1 | 2024-12-28 | 2024-12-27 | 1 | 2025-06-27 | View Edit Delete | ||||||||||||
| 771196 | 64567 | DISOLGAS 257,5 mg CAPSULAS BLANDAS. | DISOLGAS 257,5 mg CAPSULAS BLANDAS., 30 cápsulas | 257,5 mg | 5 | 32 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64567/64567_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64567/64567_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23799 | 23799 | 2002-06-26 | 1 | 1 | 1 | 2008-04-25 | 2008-04-25 | 1 | 2011-04-25 | View Edit Delete | ||||||||||||
| 783993 | 55215 | ERNODASA CÁPSULAS DURAS | ERNODASA CÁPSULAS DURAS, 20 cápsulas | 10.000 UI/2.500 UI | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/55215/55215_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/55215/55215_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 1981-09-01 | 1 | 1 | 1 | 1981-09-01 | 2003-11-24 | 1 | 2011-09-09 | 942821 | View Edit Delete | |||||||||||
| 784017 | 55215 | ERNODASA CÁPSULAS DURAS | ERNODASA CÁPSULAS DURAS, 40 cápsulas | 10.000 UI/2.500 UI | 5 | 40 | 43 | 40 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/55215/55215_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/55215/55215_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | 945 | 1981-09-01 | 1 | 1 | 1 | 1981-09-01 | 2003-11-24 | 1 | 2011-09-09 | 653295 | View Edit Delete | |||||||||||
| 908376 | 64021 | FEBROVIR 100 MG/ML SOLUCION ORAL | FEBROVIR 100 MG/ML SOLUCION ORAL, 1 frasco de 30 ml + jeringa dosificadora | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml + jeringa dosificadora | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64021/64021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64021/64021_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | 3050 | 2001-06-26 | 1 | 1 | 1 | 2001-06-26 | 2001-06-26 | 1 | 2021-10-27 | View Edit Delete | ||||||||||||
| 933424 | 52806 | EFFERALGAN 500 MG CÁPSULAS DURAS | EFFERALGAN 500 MG CÁPSULAS DURAS, 24 cápsulas | 500 mg | 5 | 24 | 43 | 24 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/52806/52806_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/52806/52806_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16744 | 44741 | 1975-02-01 | 1 | 1 | 1 | 1975-02-01 | 2005-09-26 | 1 | 2011-10-18 | 703629 | View Edit Delete |